Labiana Health, S.A. (BME:LAB)
3.440
0.00 (0.00%)
At close: May 23, 2025, 5:30 PM CET
Labiana Health Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | 0.25 | -4.42 | -8.94 | -1.78 | 1.07 | Upgrade
|
Depreciation & Amortization | 2.13 | 2.59 | 2.71 | 2.55 | 1.95 | Upgrade
|
Other Amortization | 2.12 | 2.49 | 2.12 | 2.46 | 0.93 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.12 | 0.02 | - | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | 0.95 | 0.06 | 3.54 | 0.42 | 0.05 | Upgrade
|
Other Operating Activities | -1.24 | -1 | 0.91 | -1.43 | -0.69 | Upgrade
|
Change in Accounts Receivable | 2.86 | -1.64 | -0.82 | 3.14 | -0.92 | Upgrade
|
Change in Inventory | -1.2 | 1.12 | 1.09 | -0.85 | -0.22 | Upgrade
|
Change in Accounts Payable | 1.56 | -1.96 | 4.28 | -0.61 | 1.53 | Upgrade
|
Change in Other Net Operating Assets | -0.12 | 0.91 | -0.22 | 0 | 0.08 | Upgrade
|
Operating Cash Flow | 7.19 | -1.83 | 4.68 | 3.91 | 3.79 | Upgrade
|
Operating Cash Flow Growth | - | - | 19.76% | 3.10% | - | Upgrade
|
Capital Expenditures | -3.02 | -1.66 | -2.78 | -2.3 | -4.25 | Upgrade
|
Sale of Property, Plant & Equipment | 0 | 0.02 | - | - | 0.06 | Upgrade
|
Cash Acquisitions | -0.04 | - | - | -1.1 | - | Upgrade
|
Divestitures | - | - | - | 2.36 | - | Upgrade
|
Sale (Purchase) of Intangibles | -0.03 | -0.88 | -2.67 | -2.47 | -2.48 | Upgrade
|
Investment in Securities | -0.9 | 0.49 | 2.51 | -3.72 | -0.59 | Upgrade
|
Investing Cash Flow | -3.99 | -2.03 | -2.95 | -7.23 | -7.26 | Upgrade
|
Long-Term Debt Issued | 4.37 | 19.55 | 0.74 | 8.74 | 4.62 | Upgrade
|
Long-Term Debt Repaid | -3.64 | -16.35 | -7.41 | -2.56 | -1.78 | Upgrade
|
Net Debt Issued (Repaid) | 0.73 | 3.2 | -6.67 | 6.18 | 2.84 | Upgrade
|
Issuance of Common Stock | - | 1.26 | 4.59 | - | 0.06 | Upgrade
|
Repurchase of Common Stock | -0.16 | -0.16 | -0.41 | - | - | Upgrade
|
Other Financing Activities | - | - | - | -1.13 | - | Upgrade
|
Financing Cash Flow | 0.57 | 4.3 | -2.5 | 5.06 | 2.9 | Upgrade
|
Net Cash Flow | 3.78 | 0.44 | -0.76 | 1.74 | -0.57 | Upgrade
|
Free Cash Flow | 4.18 | -3.48 | 1.9 | 1.61 | -0.46 | Upgrade
|
Free Cash Flow Growth | - | - | 17.72% | - | - | Upgrade
|
Free Cash Flow Margin | 6.20% | -5.84% | 3.12% | 2.71% | -0.76% | Upgrade
|
Free Cash Flow Per Share | - | -0.49 | - | 0.26 | -0.07 | Upgrade
|
Cash Interest Paid | 4.84 | 3.29 | 2.11 | 2.13 | 1.94 | Upgrade
|
Cash Income Tax Paid | 0.09 | 0.05 | 0.13 | 1.08 | 0.22 | Upgrade
|
Levered Free Cash Flow | 6.02 | -1.92 | 0.59 | -0.57 | -3.97 | Upgrade
|
Unlevered Free Cash Flow | 9.04 | 0.14 | 1.9 | 0.76 | -2.76 | Upgrade
|
Change in Net Working Capital | -4.66 | 1.2 | -3.91 | -0.14 | 0.13 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.